New drug cocktail aims to delay ovarian cancer return after chemo
Disease control
Not yet recruiting
This study tests whether a combination of two drugs, fluzoparib and famitinib, can help keep advanced ovarian cancer from returning after initial chemotherapy. About 43 women with stage III or IV ovarian cancer who responded well to chemo will take these pills daily for up to 2 y…
Phase: PHASE2 • Sponsor: Jinhua Zhou • Aim: Disease control
Last updated May 13, 2026 16:02 UTC